Diane K. Wysowski

6.3k total citations · 1 hit paper
49 papers, 3.8k citations indexed

About

Diane K. Wysowski is a scholar working on Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Diane K. Wysowski has authored 49 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Diane K. Wysowski's work include Poisoning and overdose treatments (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Pharmacology and Obesity Treatment (3 papers). Diane K. Wysowski is often cited by papers focused on Poisoning and overdose treatments (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Pharmacology and Obesity Treatment (3 papers). Diane K. Wysowski collaborates with scholars based in United States, Thailand and Canada. Diane K. Wysowski's co-authors include Lynette Swartz, Parivash Nourjah, Mary Rose Stang, David Butler-Jones, Laura Governale, Julie Beitz, Christian Hampp, Jean L. Fourcroy, David Moeny and Vicky Borders‐Hemphill and has published in prestigious journals such as JAMA, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Diane K. Wysowski

49 papers receiving 3.6k citations

Hit Papers

Bleeding Complications With Warfarin Use 2007 2026 2013 2019 2007 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane K. Wysowski United States 31 844 630 496 391 374 49 3.8k
Susana Perez‐Gutthann United States 30 584 0.7× 292 0.5× 864 1.7× 405 1.0× 328 0.9× 80 5.1k
Loes E. Visser Netherlands 36 775 0.9× 913 1.4× 690 1.4× 872 2.2× 868 2.3× 124 4.3k
David J. Graham United States 33 630 0.7× 654 1.0× 1.6k 3.2× 369 0.9× 244 0.7× 115 5.6k
Annalisa Capuano Italy 41 1.0k 1.2× 1.1k 1.8× 635 1.3× 247 0.6× 821 2.2× 266 5.8k
Raymond G. Schlienger Switzerland 34 332 0.4× 261 0.4× 759 1.5× 329 0.8× 300 0.8× 81 4.0k
Gerald A. Faich United States 29 255 0.3× 279 0.4× 899 1.8× 428 1.1× 154 0.4× 75 5.0k
Per Damkier Denmark 34 417 0.5× 683 1.1× 259 0.5× 719 1.8× 777 2.1× 182 4.2k
C. Michael Stein United States 35 371 0.4× 535 0.8× 1.2k 2.5× 539 1.4× 379 1.0× 109 4.2k
Marcus M. Reidenberg United States 41 239 0.3× 1.0k 1.6× 579 1.2× 710 1.8× 480 1.3× 140 4.9k
B Westerholm Sweden 22 419 0.5× 181 0.3× 454 0.9× 179 0.5× 221 0.6× 73 3.8k

Countries citing papers authored by Diane K. Wysowski

Since Specialization
Citations

This map shows the geographic impact of Diane K. Wysowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane K. Wysowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane K. Wysowski more than expected).

Fields of papers citing papers by Diane K. Wysowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane K. Wysowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane K. Wysowski. The network helps show where Diane K. Wysowski may publish in the future.

Co-authorship network of co-authors of Diane K. Wysowski

This figure shows the co-authorship network connecting the top 25 collaborators of Diane K. Wysowski. A scholar is included among the top collaborators of Diane K. Wysowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane K. Wysowski. Diane K. Wysowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hampp, Christian, Vicky Borders‐Hemphill, David Moeny, & Diane K. Wysowski. (2014). Use of Antidiabetic Drugs in the U.S., 2003–2012. Diabetes Care. 37(5). 1367–1374. 173 indexed citations
2.
Wysowski, Diane K., et al.. (2013). Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012. Bone. 57(2). 423–428. 117 indexed citations
3.
Wysowski, Diane K., et al.. (2010). Use of parenteral iron products and serious anaphylactic‐type reactions. American Journal of Hematology. 85(9). 650–654. 91 indexed citations
4.
Wysowski, Diane K.. (2007). Surveillance of Prescription Drug-Related Mortality Using Death Certificate Data. Drug Safety. 30(6). 533–540. 67 indexed citations
5.
Wysowski, Diane K. & Parivash Nourjah. (2006). Deaths Attributed to X-Ray Contrast Media on U.S. Death Certificates. American Journal of Roentgenology. 186(3). 613–615. 37 indexed citations
6.
Wysowski, Diane K., et al.. (2006). Trends in Outpatient Prescription Drug Use and Related Costs in the US. PharmacoEconomics. 24(3). 233–236. 22 indexed citations
7.
Wysowski, Diane K. & Lynette Swartz. (2005). Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002. Archives of Internal Medicine. 165(12). 1363–1363. 351 indexed citations
8.
Wysowski, Diane K. & Laura Governale. (2004). Use of menopausal hormones in the United States, 1992 through June, 2003. Pharmacoepidemiology and Drug Safety. 14(3). 171–176. 46 indexed citations
9.
Wysowski, Diane K., et al.. (2002). Use of inhalant medications with and without chlorofluorocarbon propellants in the united states, 1996-2000. Journal of Allergy and Clinical Immunology. 110(1). 51–53. 2 indexed citations
10.
Wysowski, Diane K., et al.. (2002). Use of isotretinoin (Accutane) in the United States: Rapid increase from 1992 through 2000. Journal of the American Academy of Dermatology. 46(4). 505–509. 87 indexed citations
11.
Wysowski, Diane K., et al.. (2001). Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions. The American Journal of Gastroenterology. 96(6). 1698–1703. 183 indexed citations
12.
Smalley, Walter, Deborah Shatin, Diane K. Wysowski, et al.. (2000). Contraindicated Use of Cisapride. JAMA. 284(23). 3036–3036. 191 indexed citations
13.
Wysowski, Diane K. & Jean L. Fourcroy. (1996). Flutamide Hepatotoxicity. The Journal of Urology. 209–212. 8 indexed citations
14.
Wysowski, Diane K., et al.. (1996). Sedative-hypnotic drugs and the risk of hip fracture. Journal of Clinical Epidemiology. 49(1). 111–113. 24 indexed citations
15.
Wysowski, Diane K., et al.. (1995). Serious adverse events in Norplant users related to the Food and Drug Administration's MedWatch Spontaneous Reporting System.. PubMed. 85(1). 154–20. 48 indexed citations
16.
Wysowski, Diane K., et al.. (1994). Fatal and Nonfatal Hepatotoxicity Associated With Flutamide. Obstetrical & Gynecological Survey. 49(1). 40–40. 1 indexed citations
17.
Wysowski, Diane K.. (1991). Adverse Behavioral Reactions Attributed to Triazolam in the Food and Drug Administration's Spontaneous Reporting System. Archives of Internal Medicine. 151(10). 2003–2003. 17 indexed citations
18.
Wysowski, Diane K.. (1990). Deaths due to Accidents and Violence in Two Recent Trials of Cholesterol-Lowering Drugs. Archives of Internal Medicine. 150(10). 2169–2169. 61 indexed citations
19.
Wysowski, Diane K., et al.. (1987). SEX HORMONE LEVELS IN SERUM IN RELATION TO THE DEVELOPMENT OF BREAST CANCER. American Journal of Epidemiology. 125(5). 791–799. 134 indexed citations
20.
Wysowski, Diane K.. (1979). Rh Hemolytic Disease. JAMA. 242(13). 1376–1376. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026